Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.

CONCLUSION: Dupilumab was highly effective as add-on therapy for CRSwNP in AERD, improving patient-reported outcomes, sinus opacification, and markers of T2 inflammation.
PMID: 32967430 [PubMed - as supplied by publisher]

Source: American Journal of Rhinology and Allergy - September 22, 2020 Category: ENT & OMF Authors: Mustafa SS, Vadamalai K, Scott B, Ramsey A Tags: Am J Rhinol Allergy Source Type: research